Publications by authors named "Cecile Bally"

Claim this Profile
I
Is primary hemostasis involved in bleeding diathesis in patients with type 1 glycogen storage disease?
Floriane Devaux, Claire Auditeau, Cécile Bally, Tiffany Pascreau, Anais Brassier

Thromb Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing an Assay Detecting Anti-drug Antibody against Emicizumab: Experience from One Center in France.
Claire Auditeau, Carla Valsecchi, Nûn Kalim Bentounes, Amandine Le-Goff, Annie Harroche, Cécile Bally

Thromb Haemost· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.
Elena Crisà, Elvira Mora, Ulrich Germing, Cecile Bally, Maria Diez Campelo

Leukemia· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe haemorrhages leading to a diagnosis of rare bleeding disorder occur at a very young age: A study from the FranceCoag network.
Sandrine Meunier, Annie Harroche, Antoine Rauch, Cécile Bally, Yoann Huguenin

Haemophilia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices.
Nûn K Bentounes, Dominique Lasne, Capucine Habay, Cécile Bally, Laurent Frenzel

Haemophilia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab and asparaginase, A first experience to share.
Laurie Goubeau, Cécile Bally, Delphine Borgel, Fanny Alby-Laurent, Arnaud Petit

Haemophilia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferences by factor VIII and lupus anticoagulant in the modified one-stage assay for emicizumab.
Capucine Habay, Claire Auditeau, Adeline Blandinières, Nûn K Bentounes, Cécile Lavenu-Bombled, Cecile Bally

Haemophilia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study.
Lina Khider, Marie Templé, Cécile Bally, Agathe Spaeth, Luc Darnige

J Thromb Haemost· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Marie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, Constance Lahuna, Benoit De Renzis, Cécile Bally

Clin Exp Rheumatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab does not interfere with the activated clotting time.
Ladislas Capdevila, Corinne Frère, Maximilien Desvages, Annie Harroche, Cécile Bally

Haemophilia· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient.
Annie Harroche, Thibaud Sefiane, Maximilien Desvages, Delphine Borgel, Dominique Lasne, Cécile Bally

Haematologica· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappearance of inhibitor in a tolerized patient with severe haemophilia A during FVIII-free emicizumab therapy.
Ladislas Capdevila, Delphine Borgel, Dominique Lasne, Sebastien Lacroix-Desmazes, Maximilien Desvages, Cécile Bally

Haemophilia· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique inflammatory signature in haemophilic arthropathy: miRNA changes due to interaction between blood and fibroblast-like synoviocytes.
Sandra Mignot, Nicolas Cagnard, Benoit Albaud, Cécile Bally, Justine Siavellis

J Cell Mol Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.
Pierre Peterlin, Thomas Cluzeau, Maxime Jullien, Anne-Marie Ngo Nloga, Anne Calleja, Cécile Bally

Br J Haematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic effects of PRIMA-1 (APR-246) and 5-azacitidine in -mutated myelodysplastic syndromes and acute myeloid leukemia.
Nabih Maslah, Norman Salomao, Louis Drevon, Emmanuelle Verger, Nicolas Partouche, Cecile Bally

Haematologica· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure.
Marie Sébert, Aline Renneville, Cécile Bally, Pierre Peterlin, Odile Beyne-Rauzy

Haematologica· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents.
Pedro Henrique Prata, Cécile Bally, Thomas Prebet, Christian Recher, Geoffroy Venton

Haematologica· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic analysis of therapy-related myeloid neoplasms occurring after intensive treatment for acute promyelocytic leukemia.
Aline Renneville, Philippe Attias, Xavier Thomas, Cécile Bally, Sandrine Hayette

Leukemia· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.
Jacqueline Lehmann-Che, Cécile Bally, Eric Letouzé, Caroline Berthier, Hao Yuan

Nat Commun· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Marc Hilmi, Cécile Bally, Robert Burns, Gwenael Lorillon, Anne Bergeron

Ann Hematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.
Thomas Prebet, Thomas Cluzeau, Sophie Park, Mikkael A Sekeres, Ulrich Germing, Cecile Bally

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes.
Cécile Bally, Aline Renneville, Claude Preudhomme, M Legrand, Lionel Adès

Leuk Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to therapy in acute promyelocytic leukemia.
Jacqueline Lehmann-Che, Cecile Bally, Hugues de Thé

N Engl J Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.
Cecile Bally, Lionel Adès, Aline Renneville, Marie Sebert, Virginie Eclache

Leuk Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM).
Cecile Bally, Sylvain Thépot, Bruno Quesnel, Norbert Vey, Francois Dreyfus

Leuk Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis